DK123526B - Fremgangsmåde til fremstilling af 6-chlor-2,3,4,5-tetrahydro-1H-3-benzazepin eller syreadditionssalte deraf. - Google Patents
Fremgangsmåde til fremstilling af 6-chlor-2,3,4,5-tetrahydro-1H-3-benzazepin eller syreadditionssalte deraf.Info
- Publication number
- DK123526B DK123526B DK383268AA DK383268A DK123526B DK 123526 B DK123526 B DK 123526B DK 383268A A DK383268A A DK 383268AA DK 383268 A DK383268 A DK 383268A DK 123526 B DK123526 B DK 123526B
- Authority
- DK
- Denmark
- Prior art keywords
- benzazepine
- tetrahydro
- chloro
- preparation
- acid addition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH197668A CH498122A (de) | 1968-02-09 | 1968-02-09 | Verfahren zur Herstellung eines neuen Tetrahydroazepinderivates |
Publications (1)
Publication Number | Publication Date |
---|---|
DK123526B true DK123526B (da) | 1972-07-03 |
Family
ID=4223010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK383268AA DK123526B (da) | 1968-02-09 | 1968-08-08 | Fremgangsmåde til fremstilling af 6-chlor-2,3,4,5-tetrahydro-1H-3-benzazepin eller syreadditionssalte deraf. |
Country Status (10)
Country | Link |
---|---|
AT (1) | AT277257B (xx) |
BE (1) | BE719631A (xx) |
CH (1) | CH498122A (xx) |
DE (1) | DE1795132A1 (xx) |
DK (1) | DK123526B (xx) |
ES (1) | ES357247A1 (xx) |
FR (1) | FR1598948A (xx) |
GB (1) | GB1225053A (xx) |
IL (1) | IL30458A (xx) |
NL (1) | NL6811311A (xx) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2171879A1 (en) * | 1972-02-14 | 1973-09-28 | Pennwalt Corp | 1,2,4,5-tetrahydro-3h-3-benzazepines - analgesics narcotic antagonists, antihistamines etc |
US4160765A (en) * | 1976-11-17 | 1979-07-10 | Smithkline Corporation | Method for 6-bromination of 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds |
US4197297A (en) * | 1976-11-17 | 1980-04-08 | Smithkline Corporation | 6-Halo-7,8-dihydroxy-1-(hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepines |
US4171359A (en) * | 1978-04-12 | 1979-10-16 | Smithkline Corporation | Benz-tetrasubstituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
SI2332921T1 (sl) | 2003-06-17 | 2016-06-30 | Arena Pharmaceuticals, Inc. | 8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazapin hidroklorid |
CN101274911B (zh) | 2003-06-17 | 2011-01-26 | 艾尼纳制药公司 | 用于治疗5ht2c受体相关病症的苯并氮杂卓衍生物 |
TW200510324A (en) * | 2003-08-11 | 2005-03-16 | Lilly Co Eli | 6-(2,2,2-trifluoroethylamino)-7-chiloro-2, 3, 4, 5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist |
JP5270167B2 (ja) | 2004-12-21 | 2013-08-21 | アリーナ ファーマシューティカルズ, インコーポレイテッド | (r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンザゼピン塩酸塩の結晶形 |
KR20130087622A (ko) | 2004-12-23 | 2013-08-06 | 아레나 파마슈티칼스, 인크. | 5ht2c 수용체 조정물질 조성물 및 그의 사용 방법 |
CN101466684B (zh) | 2006-04-03 | 2012-06-20 | 艾尼纳制药公司 | 8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的制备工艺和其相关中间体 |
WO2008070111A2 (en) | 2006-12-05 | 2008-06-12 | Arena Pharmaceuticals, Inc. | Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof |
WO2009111004A1 (en) | 2008-03-04 | 2009-09-11 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine |
US8952197B2 (en) | 2009-06-18 | 2015-02-10 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
KR20130112848A (ko) | 2010-06-02 | 2013-10-14 | 아레나 파마슈티칼스, 인크. | 5-ht2c 수용체 아고니스트의 제조 방법 |
SG10201506870PA (en) | 2010-09-01 | 2015-10-29 | Arena Pharm Inc | Salts of lorcaserin with optically active acids |
NZ630494A (en) | 2010-09-01 | 2016-05-27 | Arena Pharm Inc | Administration of lorcaserin to individuals with renal impairment |
SG188362A1 (en) | 2010-09-01 | 2013-04-30 | Arena Pharm Inc | Modified-release dosage forms of 5-ht2c agonists useful for weight management |
SG188361A1 (en) | 2010-09-01 | 2013-04-30 | Arena Pharm Inc | Non-hygroscopic salts of 5-ht2c agonists |
KR20150070249A (ko) | 2012-10-09 | 2015-06-24 | 아레나 파마슈티칼스, 인크. | 체중 관리 방법 |
-
1968
- 1968-02-09 CH CH197668A patent/CH498122A/de not_active IP Right Cessation
- 1968-07-29 IL IL30458A patent/IL30458A/en unknown
- 1968-08-08 NL NL6811311A patent/NL6811311A/xx unknown
- 1968-08-08 DK DK383268AA patent/DK123526B/da unknown
- 1968-08-14 ES ES357247A patent/ES357247A1/es not_active Expired
- 1968-08-14 AT AT797568A patent/AT277257B/de not_active IP Right Cessation
- 1968-08-14 DE DE19681795132 patent/DE1795132A1/de active Pending
- 1968-08-14 GB GB38772/68A patent/GB1225053A/en not_active Expired
- 1968-08-14 FR FR1598948D patent/FR1598948A/fr not_active Expired
- 1968-08-16 BE BE719631D patent/BE719631A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
GB1225053A (en) | 1971-03-17 |
IL30458A (en) | 1972-03-28 |
FR1598948A (xx) | 1970-07-15 |
NL6811311A (xx) | 1969-08-12 |
ES357247A1 (es) | 1970-03-01 |
CH498122A (de) | 1970-10-31 |
AT277257B (de) | 1969-12-29 |
BE719631A (xx) | 1969-02-17 |
IL30458A0 (en) | 1968-09-26 |
DE1795132A1 (de) | 1972-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK124884B (da) | Analogifremgangsmåde til fremstilling af 2-brom-α-ergokryptin eller syreadditionssalte deraf. | |
DK115473B (da) | Fremgangsmåde til fremstilling af 2,3,4,5-tetrahydro-1H-3-benzazepiner eller syreadditionssalte deraf. | |
DK123526B (da) | Fremgangsmåde til fremstilling af 6-chlor-2,3,4,5-tetrahydro-1H-3-benzazepin eller syreadditionssalte deraf. | |
DK131721B (da) | Analogifremgangsmåde til fremstilling af adamantanylaminer eller 3,5,7-trimethylhomologe eller syreadditionssalte deraf. | |
DK137382B (da) | Analogifremgangsmåde til fremstilling af 2,2-diaryl-4-(4'-aryl-4'-hydroxy-piperidin)butyramider eller syreadditionssalte deraf. | |
DK127644B (da) | Analogifremgangsmåde til fremstilling af ergopeptiner eller syreadditionssalte deraf. | |
DK126202B (da) | Analogifremgangsmåde til fremstilling af azepinderivater eller syreadditionssalte deraf. | |
DK120548B (da) | Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller 4-oxider eller syreadditionssalte deraf. | |
DK129994B (da) | Analogifremgangsmåde til fremstilling af 1-trimethoxybenzyl-6,7-dialkanoyl-1,2,3,4-tetrahydroisoquinoliner eller syreadditionssalte deraf. | |
DK120155B (da) | Analogifremgangsmåde til fremstilling af aminopropiofenoner eller syreadditionssalte deraf. | |
DK135231B (da) | Analogifremgangsmåde til fremstilling af basisk substituerede 2,3-cis, trans-diphenylcyclopropanderivater eller syreadditionssalte deraf. | |
DK126327B (da) | Analogifremgangsmåde til fremstilling af derivater af p-aminoalkylbenzensulfonamid eller syreadditionssalte deraf. | |
DK127424B (da) | Analogifremgangsmåde til fremstilling af 4-aryl-1-(4,4-diarylbutyl)-4-hydroxypiperidiner eller syreadditionssalte deraf. | |
DK137044B (da) | Analogifremgangsmåde til fremstilling af 4,4-diphenylhexahydroazepinderivater eller syreadditionssalte deraf. | |
DK138740B (da) | Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller syreadditionssalte deraf. | |
DK122323B (da) | Fremgangsmåde til fremstilling af 1-alkyl-(eller alkenyl)-2-aminomethylpyrrolidiner eller syreadditionssalte heraf. | |
DK130114B (da) | Analogifremgangsmåde til fremstilling af 5,6-dihydrofenantridinderivater eller syreadditionssalte eller kvaternære ammoniumsalte deraf. | |
DK121125B (da) | Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller syreadditionssalte deraf. | |
DK121955B (da) | Analogifremgangsmåde til fremstilling af 1,4-substituerede phenylpiperaziner eller syreadditionssalte deraf. | |
DK122725B (da) | Analogifremgangsmåde til fremstilling af 10,11-dihydro-5H-dibenz(b,f)azepineddikesyrederivater eller salte deraf. | |
DK135765B (da) | Fremgangsmåde til fremstilling af 1-substituerede 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoliner eller syreadditionssalte deraf. | |
DK124028B (da) | Analogifremgangsmåde til fremstilling af quinolylformiminoethere eller syreadditionssalte deraf. | |
DK113431B (da) | Fremgangsmåde til fremstilling af dibenz (b,f) azepinderivater eller syreadditionssalte deraf. | |
DK122764B (da) | Analogifremgangsmåde til fremstilling af 10, 11-dihydro-5H-dibenz [b,f] azepinderivater eller syreadditionssalte deraf. | |
DK120294B (da) | Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller syreadditionssalte deraf. |